Department of Psychiatry, EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands.
Psychosom Med. 2010 May;72(4):340-7. doi: 10.1097/PSY.0b013e3181d2f0c8. Epub 2010 Feb 26.
To examine the association between several subtypes of anxiety disorders and various cortisol indicators in a large cohort study. Anxiety disorders have been suggested to be linked to hypothalamic-pituitary-adrenal (HPA) axis activity, although results are scarce and inconsistent. No earlier studies have examined consistency of HPA axis findings across several anxiety subtypes and whether associations are state or trait dependent.
Data are derived from 1427 participants of the Netherlands Study of Depression and Anxiety. Three groups were compared: 342 control participants without psychiatric disorders; 311 persons with a remitted (no current) anxiety disorder (social phobia, generalized anxiety disorder, panic disorder); and 774 persons with a current anxiety disorder, as diagnosed using the Composite International Diagnostic Interview psychiatric interview. Cortisol levels were measured in seven saliva samples, determining the 1-hour cortisol awakening response, evening cortisol, and cortisol response after 0.5 mg of dexamethasone ingestion.
Current anxiety disorder was associated with higher awakening cortisol levels (p = .002). These findings were mainly present for patients with panic disorder with agoraphobia and anxious patients with comorbid depressive disorder. Remitted anxiety only showed a trend toward higher morning cortisol (p = .08). No associations were observed for anxiety status and evening cortisol level or cortisol suppression after dexamethasone.
This study showed a modest but significantly higher 1-hour cortisol awakening response among anxiety patients, which was driven by those with panic disorder with agoraphobia and those with comorbid depression.
在一项大型队列研究中,考察几种焦虑障碍亚型与各种皮质醇指标之间的关联。焦虑障碍与下丘脑-垂体-肾上腺(HPA)轴活动有关,尽管结果稀缺且不一致。以前的研究尚未检查几种焦虑亚型的 HPA 轴研究结果的一致性,以及这些关联是与状态相关还是与特质相关。
数据来自荷兰抑郁和焦虑研究的 1427 名参与者。将三组进行比较:342 名无精神疾病的对照参与者;311 名缓解期(无当前)焦虑障碍(社交恐惧症、广泛性焦虑症、惊恐障碍)患者;和 774 名当前患有焦虑障碍的患者,使用复合国际诊断访谈精神病学访谈进行诊断。在七个唾液样本中测量皮质醇水平,确定 1 小时皮质醇觉醒反应、傍晚皮质醇和 0.5 毫克地塞米松摄入后的皮质醇反应。
当前的焦虑障碍与较高的觉醒皮质醇水平相关(p =.002)。这些发现主要存在于伴有广场恐怖症的惊恐障碍患者和伴有共病抑郁障碍的焦虑患者中。缓解期焦虑仅表现出较高的早晨皮质醇趋势(p =.08)。地塞米松后,焦虑状态和傍晚皮质醇水平或皮质醇抑制均无相关性。
本研究显示焦虑患者的 1 小时皮质醇觉醒反应适度升高,但具有统计学意义,这主要归因于伴有广场恐怖症的惊恐障碍患者和伴有共病抑郁障碍的焦虑患者。